IP Library Granted Patent US 10,000,495
Granted Patent B2
US 10,000,495 · App. 14/982,131 · Granted Jun 19, 2018

Pyrrolotriazinones and imidazotriazinones as ubiquitin-specific protease 7 inhibitors

Inventors: Stephanos Ioannidis (Natick, MA); Adam Charles Talbot (Guilford, CT); Bruce Follows (Littleton, MA); Alexandre Joseph Buckmelter (Acton, MA); Minghua Wang (Acton, MA); Ann-Marie Campbell (Monroe, CT)
Assignee: Forma Therapeutics, Inc.
C07D487/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,000,495
App. No.
14/982,131
Granted
Jun 19, 2018
Kind
B2
Abstract

The invention relates to inhibitors of USP7 inhibitors useful in the treatment of cancers, neurodegenerative diseases, immunological disorders, inflammatory disorders, cardiovascular diseases, ischemic diseases, viral infections and diseases, and bacterial infections and diseases, having the Formula: where R 1 , R 2 , R 3 , R 4 , R 5 , R 5′ , R 6 , X 1 , X 2 , m, and n are described herein.

Claims (292)

1. A compound of Formula (I):

or a pharmaceutically acceptable salt or tautomer thereof,

wherein:

X 1 is C, S, or S(O);

X 2 is CR 7 or N;

R 1 is H, D, —OH, —SH, —NH 2 , —NH(C 1 -C 4 ) alkyl, —N((C 1 -C 4 ) alkyl) 2 , or F;

R 2 is (C 1 —C) alkyl, (C 6 -C 14 ) aryl, heteroaryl, (C 5 -C 8 ) cycloalkyl, heterocycloalkyl, —NR 25 R 26 , or —OR 25 , wherein the alkyl, aryl, heteroaryl, cycloalkyl, and heterocycloalkyl are optionally substituted with one or more R 8 ;

each R 3 is independently at each occurrence selected from D, (C 1 -C 6 ) alkyl, (C 6 -C 14 ) aryl, heteroaryl, (C 3 -C 8 ) cycloalkyl, or heterocycloalkyl, wherein the alkyl, aryl, heteroaryl, cycloalkyl and heterocycloalkyl are optionally substituted with one or more R 21 ; or

two R 3 together when on adjacent carbons form a (C 3 -C 8 ) cycloalkyl optionally substituted with one or more R 21 ; or two R 3 together form a (C 3 -C 8 ) spirocycloalkyl optionally substituted with one or more R 21 ; or two R 3 together form a spiroheterocycloalkyl optionally substituted with one or more R 21 ; or two R 3 together when on adjacent carbons form an aryl ring optionally substituted with one or more R 21 ; or two R 3 together when on adjacent carbons form an heteroaryl ring optionally substituted with one or more R 21 ;

R 4 is H, (C 1 -C 6 ) alkyl, CD 3 , (C 6 -C 14 ) aryl, heteroaryl, (C 3 -C 8 ) cycloalkyl, or heterocycloalkyl, wherein the alkyl, aryl, heteroaryl, cycloalkyl and heterocycloalkyl are optionally substituted with one or more R 22 ;

R 5 and R 5′ are independently H, D, (C 1 -C 6 ) alkyl, (C 2 -C 6 ) alkenyl, (C 2 -C 6 ) alkynyl, (C 1 -C 6 ) alkoxy, (C 1 -C 6 ) haloalkyl, (C 1 -C 6 ) haloalkoxy, —CH 2 OH, —CH 2 NH 2 , or halogen;

R 6 is H, D, or (C 1 -C 6 ) alkyl;

R 7 is H, D, (C 1 -C 6 ) alkyl, (C 2 -C 6 ) alkenyl, (C 2 -C 6 ) alkynyl, halogen, —NR 17 C(O)R 18 , CN, —P(O)((C 1 -C 6 )alkyl) 2 , —P(O)(aryl) 2 , —SiMe 3 , —SF 5 , —NR 17 C(O)NR 18 R 19 , or —C(O)NR 17 R 18 , wherein the alkyl, alkenyl, and alkynyl are optionally substituted with one or more R 21 ;

each R 8 is independently D, (C 1 -C 6 ) alkyl, (C 1 -C 6 ) alkoxy, (C 1 -C 6 ) haloalkyl, (C 1 -C 6 ) haloalkoxy, —(C 1 -C 3 )-alkylene-O(C 1 -C 6 ) alkyl, —(C 0 -C 4 )-alkylene-aryl, —(C 0 -C 4 )-alkylene-heteroaryl, (C 3 -C 10 ) cycloalkyl, heterocycloalkyl, —(C 0 -C 4 )-alkylene-O-aryl, —(C 0 -C 4 )-alkylene-O-heteroaryl, —O—(C 3 -C 8 )cycloalkyl, —S-heteroaryl, halogen, —CN, —C(O)R 12 , —CO(O)R 12 , —C(O)NR 12 R 13 , —S(O) q R 12 , —S(O) q NR 12 R 13 , —NR 12 S(O) q R 13 , —(C 0 -C 3 )-alkylene-NR 12 R 13 , —NR 12 C(O)R 13 , —NR 12 C(O)C(O)R 13 , —NR 12 C(O)NR 12 R 13 , —P(O)((C 1 -C 6 )alkyl) 2 , —P(O)(aryl) 2 , —SiMe 3 , —SF 5 , or —OR 12 , wherein alkyl, alkylene, aryl, heteroaryl, cycloalkyl, and heterocycloalkyl are optionally substituted with one or more R 9 ;

each R 9 is independently at each occurrence D, (C 1 -C 6 ) alkyl, (C 1 -C 6 ) alkoxy, (C 3 -C 8 ) cycloalkyl, heterocycloalkyl, (C 6 -C 14 ) aryl, heteroaryl, halogen, —OH, —CN, —C(O)R 14 , —C(O)NR 14 R 15 , —NR 14 C(O)R 15 , —NR 14 R 15 , —S(O) q R 14 , —S(O) q NR 14 R 15 , —NR 14 S(O) q R 15 , oxo, —P(O)((C 1 -C 6 )alkyl) 2 , —P(O)(aryl) 2 , —SiMe 3 , —SF 5 , —O-aryl, CN, or —O-heteroaryl, wherein alkyl, aryl, heteroaryl, cycloalkyl, and heterocycloalkyl are optionally substituted with one or more R 10 ; or

two R 9 together with the atoms to which they are attached form a (C 6 -C 14 ) aryl ring optionally substituted with one or more R 10 ; or two R 9 together with the atoms to which they are attached form a heteroaryl ring optionally substituted with one or more R 10 ; or two R 9 together with the atoms to which they are attached form a (C 5 -C 8 ) cycloalkyl ring optionally substituted with one or more R 10 ; or two R 9 together with the atoms to which they are attached form a heterocycloalkyl ring optionally substituted with one or more R 10 ;

each R 10 is independently at each occurrence (C 1 -C 6 ) alkyl, (C 1 -C 6 ) alkoxy, (C 1 -C 6 ) haloalkyl, (C 1 -C 6 ) haloalkoxy, halogen, —NR 23 C(O)R 24 , —NR 23 S(O) q R 24 , —C(O)R 23 , —C(O)NR 23 R 24 , —NR 23 R 24 , —S(O) q R 23 , —S(O) q NR 23 R 24 , —P(O)((C 1 -C 6 )alkyl) 2 , —P(O)(aryl) 2 , —SiMe 3 , —SF 5 , —OH, or CN; or

two R 10 together with the atoms to which they are attached form a (C 6 -C 14 ) aryl ring optionally substituted with one or more R 11 ; or two R 10 together with the atoms to which they are attached form a heteroaryl ring optionally substituted with one or more R 11 ; or two R 10 together with the atoms to which they are attached form a (C 5 -C 8 ) cycloalkyl ring optionally substituted with one or more R 11 ; or two R 10 together with the atoms to which they are attached form a heterocycloalkyl ring optionally substituted with one or more R 11 ;

each R 11 is independently at each occurrence (C 1 -C 6 ) alkyl, (C 1 -C 6 ) alkoxy, (C 1 -C 6 ) haloalkyl, (C 1 -C 6 ) haloalkoxy, halogen, —OH, —NH 2 , or CN;

each R 12 and R 13 is independently H, (C 1 -C 6 ) alkyl, (C 2 -C 6 ) alkenyl, (C 2 -C 6 ) alkynyl, (C 6 -C 14 ) aryl, heteroaryl, (C 5 -C 8 ) cycloalkyl, or heterocycloalkyl, wherein the alkyl, aryl, heteroaryl, cycloalkyl and heterocycloalkyl are optionally substituted with one or more R 16 ;

each R 14 and R 15 is independently H, (C 1 -C 6 ) alkyl, (C 2 -C 6 ) alkenyl, (C 2 -C 6 ) alkynyl, (C 6 -C 14 ) aryl, heteroaryl, (C 5 -C 8 ) cycloalkyl, or heterocycloalkyl, wherein the alkyl, aryl, heteroaryl, cycloalkyl and heterocycloalkyl are optionally substituted with one or more R 16 ; or

R 14 and R 15 together with the nitrogen to which they are attached form a heterocycloalkyl ring optionally substituted with one or more R 16 , when R 9 is —C(O)NR 14 R 15 ;

each R 16 is independently at each occurrence (C 1 -C 6 ) alkyl, (C 1 -C 6 ) alkoxy, (C 1 -C 6 ) haloalkyl, (C 1 -C 6 ) haloalkoxy, halogen, —OH, or CN;

R 17 is independently H or (C 1 -C 6 ) alkyl;

R 18 is independently (C 1 -C 6 ) alkyl, (C 6 -C 14 ) aryl, heteroaryl, (C 5 -C 8 ) cycloalkyl, or heterocycloalkyl, wherein the alkyl, aryl, heteroaryl, cycloalkyl and heterocycloalkyl are optionally substituted with one or more R 20 ;

R 19 is independently H or (C 1 -C 6 ) alkyl;

each R 20 is independently at each occurrence (C 1 -C 6 ) alkyl, (C 1 -C 6 ) alkoxy, (C 1 -C 6 ) haloalkyl, (C 1 -C 6 ) haloalkoxy, halogen, —OH, CN, (C 6 -C 14 ) aryl, —O(C 6 -C 14 ) aryl, or heteroaryl, wherein the aryl and heteroaryl are optionally substituted with one or more R 21 ; or

two R 20 together with the atoms to which they are attached form a (C 6 -C 14 ) aryl ring optionally substituted with one or more R 21 ; or two R 20 together with the atoms to which they are attached form a heteroaryl ring optionally substituted with one or more R 21 ; or two R 20 together with the atoms to which they are attached form a (C 5 -C 8 ) cycloalkyl ring optionally substituted with one or more R 21 ; or two R 20 together with the atoms to which they are attached form a heterocycloalkyl ring optionally substituted with one or more R 21 ;

each R 21 is independently at each occurrence (C 1 -C 6 ) alkyl, (C 1 -C 6 ) alkoxy, (C 1 -C 6 ) haloalkyl, (C 1 -C 6 ) haloalkoxy, halogen, —OH, or CN;

each R 22 is independently at each occurrence D, (C 1 -C 6 ) alkyl, (C 1 -C 6 ) alkoxy, (C 1 -C 6 ) haloalkyl, (C 3 -C 8 ) cycloalkyl, (C 6 -C 14 ) aryl, heteroaryl, —O-aryl, —O-heteroaryl, —O-heterocycloalkyl, —O—(C 3 -C 8 )cycloalkyl, —S(O) q (C 1 -C 6 ) alkyl, —C(O)O(C 1 -C 6 ) alkyl, —C(O)NR 23 R 24 , —S(O) q NR 23 R 24 , —NR 23 R 24 , —NR 23 C(O)NR 23 R 24 , —NR 23 C(O)OR 24 , —NR 23 S(O) q R 23 , —NR 23 C(O)R 24 , halogen, —P(O)((C 1 -C 6 )alkyl) 2 , —P(O)(aryl) 2 , —SiMe 3 , —SF 5 or —OH, wherein alkyl, aryl, heteroaryl, heterocycloalkyl, and cycloalkyl are optionally substituted with one or more substituents independently selected from (C 1 -C 6 ) alkyl, (C 1 -C 6 ) haloalkyl, (C 1 -C 6 ) alkoxy, halogen, (C 1 -C 6 ) haloalkoxy, (C 1 -C 6 ) hydroxyalkyl, —OH, CN, —NH 2 , —NH(C 1 -C 4 ) alkyl, —N((C 1 -C 4 ) alkyl) 2 , (C 6 -C 14 ) aryl, heteroaryl, cycloalkyl, or heterocycloalkyl, wherein the aryl, heteroaryl, cycloalkyl, or heterocycloalkyl are optionally substituted one or more substituents independently selected from (C 1 -C 6 ) alkyl, (C 1 -C 6 ) haloalkyl, (C 1 -C 6 ) alkoxy, halogen, (C 1 -C 6 ) haloalkoxy, (C 1 -C 6 ) hydroxyalkyl —OH, CN, —NH 2 , —NH(C 1 -C 4 ) alkyl, or —N((C 1 -C 4 ) alkyl) 2 ;

each R 23 and R 24 is independently at each occurrence H, (C 1 -C 6 ) alkyl, (C 2 -C 6 ) alkenyl, (C 2 -C 6 ) alkynyl, (C 6 -C 14 ) aryl, heteroaryl, (C 5 -C 8 ) cycloalkyl, or heterocycloalkyl;

each R 25 and R 26 is independently H, (C 1 -C 6 ) alkyl, (C 2 -C 6 ) alkenyl, (C 2 -C 6 ) alkynyl, (C 6 -C 14 ) aryl, heteroaryl, (C 5 -C 8 ) cycloalkyl, or heterocycloalkyl, wherein the alkyl, alkenyl, alkynyl, aryl, heteroaryl, cycloalkyl, and heterocycloalkyl are optionally substituted with one or more substituents independently selected from (C 1 -C 6 ) alkyl, (C 1 -C 6 ) haloalkyl, (C 1 -C 6 ) alkoxy, halogen, (C 1 -C 6 ) haloalkoxy, (C 1 -C 6 ) hydroxyalkyl, —OH, CN, —NH 2 , —NH(C 1 -C 4 ) alkyl, or —N((C 1 -C 4 ) alkyl) 2 ;

m is 0, 1, 2, 3, or 4;

n is 0, 1, 2, or 3; and

q is independently at each occurrence 0, 1, or 2.

2. The compound of claim 1 , wherein X 1 is C.

3. The compound of claim 1 , wherein X 2 is N.

4. The compound of claim 1 , wherein X 2 is CR 7 .

5. The compound of claim 1 , wherein R 1 is —OH.

6. The compound of claim 1 , wherein R 4 is H or (C 1 -C 6 ) alkyl.

7. The compound of claim 1 , wherein R 5 is H.

8. The compound of claim 1 , wherein R 5′ is H.

9. The compound of claim 1 , wherein R 6 is H.

10. The compound of claim 1 , wherein R 7 is H, halogen, —NR 17 C(O)R 18 , or —NR 17 C(O)NR 18 R 19 .

11. The compound of claim 1 , having Formula (Ia), Formula (Ib), Formula (Ic), or Formula (Id):

or a pharmaceutically acceptable salt or tautomer thereof,

wherein:

X 1 is C, S, or S(O);

R 2 is (C 1 -C 8 ) alkyl, (C 6 -C 14 ) aryl, heteroaryl, (C 5 -C 8 ) cycloalkyl, heterocycloalkyl, —NR 25 R 26 , or —OR 25 , wherein the alkyl, aryl, heteroaryl, cycloalkyl, and heterocycloalkyl are optionally substituted with one or more R 8 ;

each R 3 is independently at each occurrence selected from D, (C 1 -C 6 ) alkyl, (C 6 -C 14 ) aryl, heteroaryl, (C 3 -C 8 ) cycloalkyl, or heterocycloalkyl, wherein the alkyl, aryl, heteroaryl, cycloalkyl and heterocycloalkyl are optionally substituted with one or more R 21 ; or

two R 3 together when on adjacent carbons form a (C 3 -C 8 ) cycloalkyl optionally substituted with one or more R 21 ; or two R 3 together form a (C 3 -C 8 ) spirocycloalkyl optionally substituted with one or more R 21 ; or two R 3 together form a spiroheterocycloalkyl optionally substituted with one or more R 21 ; or two R 3 together when on adjacent carbons form an aryl ring optionally substituted with one or more R 21 ; or two R 3 together when on adjacent carbons form an heteroaryl ring optionally substituted with one or more R 21 ;

R 4 is H, (C 1 -C 6 ) alkyl, CD 3 , (C 6 -C 14 ) aryl, heteroaryl, (C 3 -C 8 ) cycloalkyl, or heterocycloalkyl, wherein the alkyl, aryl, heteroaryl, cycloalkyl and heterocycloalkyl are optionally substituted with one or more R 22 ;

R 6 is H, D, or (C 1 -C 6 ) alkyl;

R 7 is H, D, (C 1 -C 6 ) alkyl, (C 2 -C 6 ) alkenyl, (C 2 -C 6 ) alkynyl, halogen, —NR 17 C(O)R 18 , CN, —P(O)((C 1 -C 6 )alkyl) 2 , —P(O)(aryl) 2 , —SiMe 3 , —SF 5 , —NR 17 C(O)NR 18 R 19 , or —C(O)NR 17 R 18 , wherein the alkyl, alkenyl, and alkynyl are optionally substituted with one or more R 21 ;

each R 8 is independently D, (C 1 -C 6 ) alkyl, (C 1 -C 6 ) alkoxy, (C 1 -C 6 ) haloalkyl, (C 1 -C 6 ) haloalkoxy, —(C 1 -C 3 )-alkylene-O(C 1 -C 6 ) alkyl, —(C 0 -C 4 )-alkylene-aryl, —(C 0 -C 4 )-alkylene-heteroaryl, (C 3 -C 10 ) cycloalkyl, heterocycloalkyl, —(C 0 -C 4 )-alkylene-O-aryl, —(C 0 -C 4 )-alkylene-O-heteroaryl, —O—(C 3 -C 8 )cycloalkyl, —S-heteroaryl, halogen, —CN, —C(O)R 12 , —CO(O)R 12 , —C(O)NR 12 R 13 , —S(O) q R 12 , —S(O) q NR 12 R 13 , —NR 12 S(O) q R 13 , —(C 0 -C 3 )-alkylene-NR 12 R 13 , —NR 12 C(O)R 13 , —NR 12 C(O)C(O)R 13 , —NR 12 C(O)NR 12 R 13 , —P(O)((C 1 -C 6 )alkyl) 2 , —P(O)(aryl) 2 , —SiMe 3 , —SF 5 , or —OR 12 wherein alkyl, alkylene, aryl, heteroaryl, cycloalkyl, and heterocycloalkyl are optionally substituted with one or more R 9 ;

each R 9 is independently at each occurrence D, (C 1 -C 6 ) alkyl, (C 1 -C 6 ) alkoxy, (C 3 -C 8 ) cycloalkyl, heterocycloalkyl, (C 6 -C 14 ) aryl, heteroaryl, halogen, —OH, —CN, —C(O)R 14 , —C(O)NR 14 R 15 , —NR 14 C(O)R 15 , —NR 14 R 15 , —S(O) q R 14 , —S(O) q NR 14 R 15 , —NR 14 S(O) q R 15 , oxo, —P(O)((C 1 -C 6 )alkyl) 2 , —P(O)(aryl) 2 , —SiMe 3 , —SF 5 , —O-aryl, CN, or —O-heteroaryl, wherein alkyl, aryl, heteroaryl, cycloalkyl, and heterocycloalkyl are optionally substituted with one or more R 10 ; or

two R 9 together with the atoms to which they are attached form a (C 6 -C 14 ) aryl ring optionally substituted with one or more R 10 ; or two R 9 together with the atoms to which they are attached form a heteroaryl ring optionally substituted with one or more R 10 ; or two R 9 together with the atoms to which they are attached form a (C 5 -C 8 ) cycloalkyl ring optionally substituted with one or more R 10 ; or two R 9 together with the atoms to which they are attached form a heterocycloalkyl ring optionally substituted with one or more R 10 ;

each R 10 is independently at each occurrence (C 1 -C 6 ) alkyl, (C 1 -C 6 ) alkoxy, (C 1 -C 6 ) haloalkyl, (C 1 -C 6 ) haloalkoxy, halogen, —NR 23 C(O)R 24 , —NR 23 S(O) q R 24 , —C(O)R 23 , —C(O)NR 23 R 24 , —NR 23 R 24 , —S(O) q R 23 , —S(O) q NR 23 R 24 , —P(O)((C 1 -C 6 )alkyl) 2 , —P(O)(aryl) 2 , —SiMe 3 , —SF 5 , —OH, or CN; or

two R 10 together with the atoms to which they are attached form a (C 6 -C 14 ) aryl ring optionally substituted with one or more R 11 ; or two R 10 together with the atoms to which they are attached form a heteroaryl ring optionally substituted with one or more R 11 ; or two R 10 together with the atoms to which they are attached form a (C 5 -C 8 ) cycloalkyl ring optionally substituted with one or more R 11 ; or two R 10 together with the atoms to which they are attached form a heterocycloalkyl ring optionally substituted with one or more R 11 ;

each R 11 is independently at each occurrence (C 1 -C 6 ) alkyl, (C 1 -C 6 ) alkoxy, (C 1 -C 6 ) haloalkyl, (C 1 -C 6 ) haloalkoxy, halogen, —OH, —NH 2 , or CN;

each R 12 and R 13 is independently H, (C 1 -C 6 ) alkyl, (C 2 -C 6 ) alkenyl, (C 2 -C 6 ) alkynyl, (C 6 -C 14 ) aryl, heteroaryl, (C 5 -C 8 ) cycloalkyl, or heterocycloalkyl, wherein the alkyl, aryl, heteroaryl, cycloalkyl and heterocycloalkyl are optionally substituted with one or more R 16 ;

each R 14 and R 15 is independently H, (C 1 -C 6 ) alkyl, (C 2 -C 6 ) alkenyl, (C 2 -C 6 ) alkynyl, (C 6 -C 14 ) aryl, heteroaryl, (C 5 -C 8 ) cycloalkyl, or heterocycloalkyl, wherein the alkyl, aryl, heteroaryl, cycloalkyl and heterocycloalkyl are optionally substituted with one or more R 16 ; or

R 14 and R 15 together with the nitrogen to which they are attached form a heterocycloalkyl ring optionally substituted with one or more R 16 , when R 9 is —C(O)NR 14 R 15 ;

each R 16 is independently at each occurrence (C 1 -C 6 ) alkyl, (C 1 -C 6 ) alkoxy, (C 1 -C 6 ) haloalkyl, (C 1 -C 6 ) haloalkoxy, halogen, —OH, or CN;

R 17 is independently H or (C 1 -C 6 ) alkyl;

R 18 is independently (C 1 -C 6 ) alkyl, (C 6 -C 14 ) aryl, heteroaryl, (C 5 -C 8 ) cycloalkyl, or heterocycloalkyl, wherein the alkyl, aryl, heteroaryl, cycloalkyl and heterocycloalkyl are optionally substituted with one or more R 20 ;

R 19 is independently H or (C 1 -C 6 ) alkyl;

each R 20 is independently at each occurrence (C 1 -C 6 ) alkyl, (C 1 -C 6 ) alkoxy, (C 1 -C 6 ) haloalkyl, (C 1 -C 6 ) haloalkoxy, halogen, —OH, CN, (C 6 -C 14 ) aryl, —O(C 6 -C 14 ) aryl, or heteroaryl, wherein the aryl and heteroaryl are optionally substituted with one or more R 21 ; or

two R 20 together with the atoms to which they are attached form a (C 6 -C 14 ) aryl ring optionally substituted with one or more R 21 ; or two R 20 together with the atoms to which they are attached form a heteroaryl ring optionally substituted with one or more R 21 ; or two R 20 together with the atoms to which they are attached form a (C 5 -C 8 ) cycloalkyl ring optionally substituted with one or more R 21 ; or two R 20 together with the atoms to which they are attached form a heterocycloalkyl ring optionally substituted with one or more R 21 ;

each R 21 is independently at each occurrence (C 1 -C 6 ) alkyl, (C 1 -C 6 ) alkoxy, (C 1 -C 6 ) haloalkyl, (C 1 -C 6 ) haloalkoxy, halogen, —OH, or CN;

each R 22 is independently at each occurrence D, (C 1 -C 6 ) alkyl, (C 1 -C 6 ) alkoxy, (C 1 -C 6 ) haloalkyl, (C 3 -C 8 ) cycloalkyl, (C 6 -C 14 ) aryl, heteroaryl, —O-aryl, —O-heteroaryl, —O-heterocycloalkyl, —O—(C 3 -C 8 )cycloalkyl, —S(O) q (C 1 -C 6 ) alkyl, —C(O)O(C 1 -C 6 ) alkyl, —C(O)NR 23 R 24 , —S(O) q NR 23 R 24 , —NR 23 R 24 , —NR 23 C(O)NR 23 R 24 , —NR 23 C(O)OR 24 , —NR 23 S(O) q R 23 , —NR 23 C(O)R 24 , halogen, —P(O)((C 1 -C 6 )alkyl) 2 , —P(O)(aryl) 2 , —SiMe 3 , —SF 5 or —OH, wherein alkyl, aryl, heteroaryl, heterocycloalkyl, and cycloalkyl are optionally substituted with one or more substituents independently selected from (C 1 -C 6 ) alkyl, (C 1 -C 6 ) haloalkyl, (C 1 -C 6 ) alkoxy, halogen, (C 1 -C 6 ) haloalkoxy, (C 1 -C 6 ) hydroxyalkyl, —OH, CN, —NH 2 , —NH(C 1 -C 4 ) alkyl, —N((C 1 -C 4 ) alkyl) 2 , (C 6 -C 14 ) aryl, heteroaryl, cycloalkyl, or heterocycloalkyl, wherein the aryl, heteroaryl, cycloalkyl, or heterocycloalkyl are optionally substituted one or more substituents independently selected from (C 1 -C 6 ) alkyl, (C 1 -C 6 ) haloalkyl, (C 1 -C 6 ) alkoxy, halogen, (C 1 -C 6 ) haloalkoxy, (C 1 -C 6 ) hydroxyalkyl —OH, CN, —NH 2 , —NH(C 1 -C 4 ) alkyl, or —N((C 1 -C 4 ) alkyl) 2 ;

each R 23 and R 24 is independently at each occurrence H, (C 1 -C 6 ) alkyl, (C 2 -C 6 ) alkenyl, (C 2 -C 6 ) alkynyl, (C 6 -C 14 ) aryl, heteroaryl, (C 5 -C 8 ) cycloalkyl, or heterocycloalkyl;

each R 25 and R 26 is independently H, (C 1 -C 6 ) alkyl, (C 2 -C 6 ) alkenyl, (C 2 -C 6 ) alkynyl, (C 6 -C 14 ) aryl, heteroaryl, (C 5 -C 8 ) cycloalkyl, or heterocycloalkyl, wherein the alkyl, alkenyl, alkynyl, aryl, heteroaryl, cycloalkyl, and heterocycloalkyl are optionally substituted with one or more substituents independently selected from (C 1 -C 6 ) alkyl, (C 1 -C 6 ) haloalkyl, (C 1 -C 6 ) alkoxy, halogen, (C 1 -C 6 ) haloalkoxy, (C 1 -C 6 ) hydroxyalkyl, —OH, CN, —NH 2 , —NH(C 1 -C 4 ) alkyl, or —N((C 1 -C 4 ) alkyl) 2 ;

m is 0, 1, 2, 3, or 4; and

q is independently at each occurrence 0, 1, or 2.

12. The compound of claim 1 , having Formula (Ie) or Formula (If):

or a pharmaceutically acceptable salt or tautomer thereof,

wherein:

X 1 is C, S, or S(O);

Ar is (C 6 -C 14 ) aryl or heteroaryl, wherein the aryl and heteroaryl are optionally substituted with one or more R 8 ;

each R 3 is independently at each occurrence selected from D, (C 1 -C 6 ) alkyl, (C 6 -C 14 ) aryl, heteroaryl, (C 3 -C 8 ) cycloalkyl, or heterocycloalkyl, wherein the alkyl, aryl, heteroaryl, cycloalkyl and heterocycloalkyl are optionally substituted with one or more R 21 ; or

two R 3 together when on adjacent carbons form a (C 3 -C 8 ) cycloalkyl optionally substituted with one or more R 21 ; or two R 3 together form a (C 3 -C 8 ) spirocycloalkyl optionally substituted with one or more R 21 ; or two R 3 together form a spiroheterocycloalkyl optionally substituted with one or more R 21 ; or two R 3 together when on adjacent carbons form an aryl ring optionally substituted with one or more R 21 ; or two R 3 together when on adjacent carbons form an heteroaryl ring optionally substituted with one or more R 21 ;

R 4 is H, (C 1 -C 6 ) alkyl, CD 3 , (C 6 -C 14 ) aryl, heteroaryl, (C 3 -C 8 ) cycloalkyl, or heterocycloalkyl, wherein the alkyl, aryl, heteroaryl, cycloalkyl and heterocycloalkyl are optionally substituted with one or more R 22 ;

R 6 is H, D, or (C 1 -C 6 ) alkyl;

R 7 is H, D, (C 1 -C 6 ) alkyl, (C 2 -C 6 ) alkenyl, (C 2 -C 6 ) alkynyl, halogen, —NR 17 C(O)R 18 , CN, —P(O)((C 1 -C 6 )alkyl) 2 , —P(O)(aryl) 2 , —SiMe 3 , —SF 5 , —NR 17 C(O)NR 18 R 19 , or —C(O)NR 17 R 18 , wherein the alkyl, alkenyl, and alkynyl are optionally substituted with one or more R 21 ;

each R 8 is independently D, (C 1 -C 6 ) alkyl, (C 1 -C 6 ) alkoxy, (C 1 -C 6 ) haloalkyl, (C 1 -C 6 ) haloalkoxy, —(C 1 -C 3 )-alkylene-O(C 1 -C 6 ) alkyl, —(C 0 -C 4 )-alkylene-aryl, —(C 0 -C 4 )-alkylene-heteroaryl, (C 3 -C 10 ) cycloalkyl, heterocycloalkyl, —(C 0 -C 4 )-alkylene-O-aryl, —(C 0 -C 4 )-alkylene-O-heteroaryl, —O—(C 3 -C 8 )cycloalkyl, —S-heteroaryl, halogen, —CN, —C(O)R 12 , —CO(O)R 12 , —C(O)NR 12 R 13 , —S(O) q R 12 , —S(O) q NR 12 R 13 , —NR 12 S(O) q R 13 , —(C 0 -C 3 )-alkylene-NR 12 R 13 , —NR 12 C(O)R 13 , —NR 12 C(O)C(O)R 13 , —NR 12 C(O)NR 12 R 13 , —P(O)((C 1 -C 6 )alkyl) 2 , —P(O)(aryl) 2 , —SiMe 3 , —SF 5 , or —OR 12 , wherein alkyl, alkylene, aryl, heteroaryl, cycloalkyl, and heterocycloalkyl are optionally substituted with one or more R 9 ;

each R 9 is independently at each occurrence D, (C 1 -C 6 ) alkyl, (C 1 -C 6 ) alkoxy, (C 3 -C 8 ) cycloalkyl, heterocycloalkyl, (C 6 -C 14 ) aryl, heteroaryl, halogen, —OH, —CN, —C(O)R 14 , —C(O)NR 14 R 15 , —NR 14 C(O)R 15 , —NR 14 R 15 , —S(O) q R 14 , —S(O) q NR 14 R 15 , —NR 14 S(O) q R 15 , oxo, —P(O)((C 1 -C 6 )alkyl) 2 , —P(O)(aryl) 2 , —SiMe 3 , —SF 5 , —O-aryl, CN, or —O-heteroaryl, wherein alkyl, aryl, heteroaryl, cycloalkyl, and heterocycloalkyl are optionally substituted with one or more R 10 ; or

two R 9 together with the atoms to which they are attached form a (C 6 -C 14 ) aryl ring optionally substituted with one or more R 10 ; or two R 9 together with the atoms to which they are attached form a heteroaryl ring optionally substituted with one or more R 10 ; or two R 9 together with the atoms to which they are attached form a (C 5 -C 8 ) cycloalkyl ring optionally substituted with one or more R 10 ; or two R 9 together with the atoms to which they are attached form a heterocycloalkyl ring optionally substituted with one or more R 10 ;

each R 10 is independently at each occurrence (C 1 -C 6 ) alkyl, (C 1 -C 6 ) alkoxy, (C 1 -C 6 ) haloalkyl, (C 1 -C 6 ) haloalkoxy, halogen, —NR 23 C(O)R 24 , —NR 23 S(O) q R 24 , —C(O)R 23 , —C(O)NR 23 R 24 , —NR 23 R 24 , —S(O) q R 23 , —S(O) q NR 23 R 24 , —P(O)((C 1 -C 6 )alkyl) 2 , —P(O)(aryl) 2 , —SiMe 3 , —SF 5 , —OH, or CN; or

two R 10 together with the atoms to which they are attached form a (C 6 -C 14 ) aryl ring optionally substituted with one or more R 11 ; or two R 10 together with the atoms to which they are attached form a heteroaryl ring optionally substituted with one or more R 11 ; or two R 10 together with the atoms to which they are attached form a (C 5 -C 8 ) cycloalkyl ring optionally substituted with one or more R 11 ; or two R 10 together with the atoms to which they are attached form a heterocycloalkyl ring optionally substituted with one or more R 11 ;

each R 11 is independently at each occurrence (C 1 -C 6 ) alkyl, (C 1 -C 6 ) alkoxy, (C 1 -C 6 ) haloalkyl, (C 1 -C 6 ) haloalkoxy, halogen, —OH, —NH 2 , or CN;

each R 12 and R 13 is independently H, (C 1 -C 6 ) alkyl, (C 2 -C 6 ) alkenyl, (C 2 -C 6 ) alkynyl, (C 6 -C 14 ) aryl, heteroaryl, (C 5 -C 8 ) cycloalkyl, or heterocycloalkyl, wherein the alkyl, aryl, heteroaryl, cycloalkyl and heterocycloalkyl are optionally substituted with one or more R 16 ;

each R 14 and R 15 is independently H, (C 1 -C 6 ) alkyl, (C 2 -C 6 ) alkenyl, (C 2 -C 6 ) alkynyl, (C 6 -C 14 ) aryl, heteroaryl, (C 5 -C 8 ) cycloalkyl, or heterocycloalkyl, wherein the alkyl, aryl, heteroaryl, cycloalkyl and heterocycloalkyl are optionally substituted with one or more R 16 ; or

R 14 and R 15 together with the nitrogen to which they are attached form a heterocycloalkyl ring optionally substituted with one or more R 16 , when R 9 is —C(O)NR 14 R 15 ;

each R 16 is independently at each occurrence (C 1 -C 6 ) alkyl, (C 1 -C 6 ) alkoxy, (C 1 -C 6 ) haloalkyl, (C 1 -C 6 ) haloalkoxy, halogen, —OH, or CN;

R 17 is independently H or (C 1 -C 6 ) alkyl;

R 18 is independently (C 1 -C 6 ) alkyl, (C 6 -C 14 ) aryl, heteroaryl, (C 5 -C 8 ) cycloalkyl, or heterocycloalkyl, wherein the alkyl, aryl, heteroaryl, cycloalkyl and heterocycloalkyl are optionally substituted with one or more R 20 ;

R 19 is independently H or (C 1 -C 6 ) alkyl;

each R 20 is independently at each occurrence (C 1 -C 6 ) alkyl, (C 1 -C 6 ) alkoxy, (C 1 -C 6 ) haloalkyl, (C 1 -C 6 ) haloalkoxy, halogen, —OH, CN, (C 6 -C 14 ) aryl, —O(C 6 -C 14 ) aryl, or heteroaryl, wherein the aryl and heteroaryl are optionally substituted with one or more R 21 ; or

two R 20 together with the atoms to which they are attached form a (C 6 -C 14 ) aryl ring optionally substituted with one or more R 21 ; or two R 20 together with the atoms to which they are attached form a heteroaryl ring optionally substituted with one or more R 21 ; or two R 20 together with the atoms to which they are attached form a (C 5 -C 8 ) cycloalkyl ring optionally substituted with one or more R 21 ; or two R 20 together with the atoms to which they are attached form a heterocycloalkyl ring optionally substituted with one or more R 21 ;

each R 21 is independently at each occurrence (C 1 -C 6 ) alkyl, (C 1 -C 6 ) alkoxy, (C 1 -C 6 ) haloalkyl, (C 1 -C 6 ) haloalkoxy, halogen, —OH, or CN;

each R 22 is independently at each occurrence D, (C 1 -C 6 ) alkyl, (C 1 -C 6 ) alkoxy, (C 1 -C 6 ) haloalkyl, (C 3 -C 8 ) cycloalkyl, (C 6 -C 14 ) aryl, heteroaryl, —O-aryl, —O-heteroaryl, —O-heterocycloalkyl, —O—(C 3 -C 8 )cycloalkyl, —S(O) q (C 1 -C 6 ) alkyl, —C(O)O(C 1 -C 6 ) alkyl, —C(O)NR 23 R 24 , —S(O) q NR 23 R 24 , —NR 23 R 24 , —NR 23 C(O)NR 23 R 24 , —NR 23 C(O)OR 24 , —NR 23 S(O) q R 23 , —NR 23 C(O)R 24 , halogen, —P(O)((C 1 -C 6 )alkyl) 2 , —P(O)(aryl) 2 , —SiMe 3 , —SF 5 or —OH, wherein alkyl, aryl, heteroaryl, heterocycloalkyl, and cycloalkyl are optionally substituted with one or more substituents independently selected from (C 1 -C 6 ) alkyl, (C 1 -C 6 ) haloalkyl, (C 1 -C 6 ) alkoxy, halogen, (C 1 -C 6 ) haloalkoxy, (C 1 -C 6 ) hydroxyalkyl, —OH, CN, —NH 2 , —NH(C 1 -C 4 ) alkyl, —N((C 1 -C 4 ) alkyl) 2 , (C 6 -C 14 ) aryl, heteroaryl, cycloalkyl, or heterocycloalkyl, wherein the aryl, heteroaryl, cycloalkyl, or heterocycloalkyl are optionally substituted one or more substituents independently selected from (C 1 -C 6 ) alkyl, (C 1 -C 6 ) haloalkyl, (C 1 -C 6 ) alkoxy, halogen, (C 1 -C 6 ) haloalkoxy, (C 1 -C 6 ) hydroxyalkyl —OH, CN, —NH 2 , —NH(C 1 -C 4 ) alkyl, or —N((C 1 -C 4 ) alkyl) 2 ;

each R 23 and R 24 is independently at each occurrence H, (C 1 -C 6 ) alkyl, (C 2 -C 6 ) alkenyl, (C 2 -C 6 ) alkynyl, (C 6 -C 14 ) aryl, heteroaryl, (C 5 -C 8 ) cycloalkyl, or heterocycloalkyl;

each m is independently at each occurrence 0, 1, 2, 3, or 4; and

q is independently at each occurrence 0, 1, or 2.

13. The compound of claim 1 , having Formula (Ig) or Formula (Ih):

or a pharmaceutically acceptable salt or tautomer thereof,

wherein:

X 1 is C, S, or S(O);

Cy is (C 5 -C 8 ) cycloalkyl or heterocycloalkyl, wherein the cycloalkyl and heterocycloalkyl are optionally substituted with one or more R 8 ;

each R 3 is independently at each occurrence selected from D, (C 1 -C 6 ) alkyl, (C 6 -C 14 ) aryl, heteroaryl, (C 3 -C 8 ) cycloalkyl, or heterocycloalkyl, wherein the alkyl, aryl, heteroaryl, cycloalkyl and heterocycloalkyl are optionally substituted with one or more R 21 ; or

two R 3 together when on adjacent carbons form a (C 3 -C 8 ) cycloalkyl optionally substituted with one or more R 21 ; or two R 3 together form a (C 3 -C 8 ) spirocycloalkyl optionally substituted with one or more R 21 ; or two R 3 together form a spiroheterocycloalkyl optionally substituted with one or more R 21 ; or two R 3 together when on adjacent carbons form an aryl ring optionally substituted with one or more R 21 ; or two R 3 together when on adjacent carbons form an heteroaryl ring optionally substituted with one or more R 21 ;

R 4 is H, (C 1 -C 6 ) alkyl, CD 3 , (C 6 -C 14 ) aryl, heteroaryl, (C 3 -C 8 ) cycloalkyl, or heterocycloalkyl, wherein the alkyl, aryl, heteroaryl, cycloalkyl and heterocycloalkyl are optionally substituted with one or more R 22 ;

R 6 is H, D, or (C 1 -C 6 ) alkyl;

R 7 is H, D, (C 1 -C 6 ) alkyl, (C 2 -C 6 ) alkenyl, (C 2 -C 6 ) alkynyl, halogen, —NR 17 C(O)R 18 , CN, —P(O)((C 1 -C 6 )alkyl) 2 , —P(O)(aryl) 2 , —SiMe 3 , —SF 5 , —NR 17 C(O)NR 18 R 19 , or —C(O)NR 17 R 18 , wherein the alkyl, alkenyl, and alkynyl are optionally substituted with one or more R 21 ;

each R 8 is independently D, (C 1 -C 6 ) alkyl, (C 1 -C 6 ) alkoxy, (C 1 -C 6 ) haloalkyl, (C 1 -C 6 ) haloalkoxy, —(C 1 -C 3 )-alkylene-O(C 1 -C 6 ) alkyl, —(C 0 -C 4 )-alkylene-aryl, —(C 0 -C 4 )-alkylene-heteroaryl, (C 3 -C 10 ) cycloalkyl, heterocycloalkyl, —(C 0 -C 4 )-alkylene-O-aryl, —(C 0 -C 4 )-alkylene-O-heteroaryl, —O—(C 3 -C 8 )cycloalkyl, —S-heteroaryl, halogen, —CN, —C(O)R 12 , —CO(O)R 12 , —C(O)NR 12 R 13 , —S(O) q R 12 , —S(O) q NR 12 R 13 , —NR 12 S(O) q R 13 , —(C 0 -C 3 )-alkylene-NR 12 R 13 , —NR 12 C(O)R 13 , —NR 12 C(O)C(O)R 13 , —NR 12 C(O)NR 12 R 13 , —P(O)((C 1 -C 6 )alkyl) 2 , —P(O)(aryl) 2 , —SiMe 3 , —SF 5 , or —OR 12 , wherein alkyl, alkylene, aryl, heteroaryl, cycloalkyl, and heterocycloalkyl are optionally substituted with one or more R 9 ;

each R 9 is independently at each occurrence D, (C 1 -C 6 ) alkyl, (C 1 -C 6 ) alkoxy, (C 3 -C 8 ) cycloalkyl, heterocycloalkyl, (C 6 -C 14 ) aryl, heteroaryl, halogen, —OH, —CN, —C(O)R 14 , —C(O)NR 14 R 15 , —NR 14 C(O)R 15 , —NR 14 R 15 , —S(O) q R 14 , —S(O) q NR 14 R 15 , —NR 14 S(O) q R 15 , oxo, —P(O)((C 1 -C 6 )alkyl) 2 , —P(O)(aryl) 2 , —SiMe 3 , —SF 5 , —O-aryl, CN, or —O-heteroaryl, wherein alkyl, aryl, heteroaryl, cycloalkyl, and heterocycloalkyl are optionally substituted with one or more R 10 ; or

two R 9 together with the atoms to which they are attached form a (C 6 -C 14 ) aryl ring optionally substituted with one or more R 10 ; or two R 9 together with the atoms to which they are attached form a heteroaryl ring optionally substituted with one or more R 10 ; or two R 9 together with the atoms to which they are attached form a (C 5 -C 8 ) cycloalkyl ring optionally substituted with one or more R 10 ; or two R 9 together with the atoms to which they are attached form a heterocycloalkyl ring optionally substituted with one or more R 10 ;

each R 10 is independently at each occurrence (C 1 -C 6 ) alkyl, (C 1 -C 6 ) alkoxy, (C 1 -C 6 ) haloalkyl, (C 1 -C 6 ) haloalkoxy, halogen, —NR 23 C(O)R 24 , —NR 23 S(O) q R 24 , —C(O)R 23 , —C(O)NR 23 R 24 , —NR 23 R 24 , —S(O) q R 23 , —S(O) q NR 23 R 24 , —P(O)((C 1 -C 6 )alkyl) 2 , —P(O)(aryl) 2 , —SiMe 3 , —SF 5 , —OH, or CN; or

two R 10 together with the atoms to which they are attached form a (C 6 -C 14 ) aryl ring optionally substituted with one or more R 11 ; or two R 10 together with the atoms to which they are attached form a heteroaryl ring optionally substituted with one or more R 11 ; or two R 10 together with the atoms to which they are attached form a (C 5 -C 8 ) cycloalkyl ring optionally substituted with one or more R 11 ; or two R 10 together with the atoms to which they are attached form a heterocycloalkyl ring optionally substituted with one or more R 11 ;

each R 11 is independently at each occurrence (C 1 -C 6 ) alkyl, (C 1 -C 6 ) alkoxy, (C 1 -C 6 ) haloalkyl, (C 1 -C 6 ) haloalkoxy, halogen, —OH, —NH 2 , or CN;

each R 12 and R 13 is independently H, (C 1 -C 6 ) alkyl, (C 2 -C 6 ) alkenyl, (C 2 -C 6 ) alkynyl, (C 6 -C 14 ) aryl, heteroaryl, (C 5 -C 8 ) cycloalkyl, or heterocycloalkyl, wherein the alkyl, aryl, heteroaryl, cycloalkyl and heterocycloalkyl are optionally substituted with one or more R 16 ;

each R 14 and R 15 is independently H, (C 1 -C 6 ) alkyl, (C 2 -C 6 ) alkenyl, (C 2 -C 6 ) alkynyl, (C 6 -C 14 ) aryl, heteroaryl, (C 5 -C 8 ) cycloalkyl, or heterocycloalkyl, wherein the alkyl, aryl, heteroaryl, cycloalkyl and heterocycloalkyl are optionally substituted with one or more R 16 ; or

R 14 and R 15 together with the nitrogen to which they are attached form a heterocycloalkyl ring optionally substituted with one or more R 16 , when R 9 is —C(O)NR 14 R 15 ;

each R 16 is independently at each occurrence (C 1 -C 6 ) alkyl, (C 1 -C 6 ) alkoxy, (C 1 -C 6 ) haloalkyl, (C 1 -C 6 ) haloalkoxy, halogen, —OH, or CN;

R 17 is independently H or (C 1 -C 6 ) alkyl;

R 18 is independently (C 1 -C 6 ) alkyl, (C 6 -C 14 ) aryl, heteroaryl, (C 5 -C 8 ) cycloalkyl, or heterocycloalkyl, wherein the alkyl, aryl, heteroaryl, cycloalkyl and heterocycloalkyl are optionally substituted with one or more R 20 ;

R 19 is independently H or (C 1 -C 6 ) alkyl;

each R 20 is independently at each occurrence (C 1 -C 6 ) alkyl, (C 1 -C 6 ) alkoxy, (C 1 -C 6 ) haloalkyl, (C 1 -C 6 ) haloalkoxy, halogen, —OH, CN, (C 6 -C 14 ) aryl, —O(C 6 -C 14 ) aryl, or heteroaryl, wherein the aryl and heteroaryl are optionally substituted with one or more R 21 ; or

two R 20 together with the atoms to which they are attached form a (C 6 -C 14 ) aryl ring optionally substituted with one or more R 21 ; or two R 20 together with the atoms to which they are attached form a heteroaryl ring optionally substituted with one or more R 21 ; or two R 20 together with the atoms to which they are attached form a (C 5 -C 8 ) cycloalkyl ring optionally substituted with one or more R 21 ; or two R 20 together with the atoms to which they are attached form a heterocycloalkyl ring optionally substituted with one or more R 21 ;

each R 21 is independently at each occurrence (C 1 -C 6 ) alkyl, (C 1 -C 6 ) alkoxy, (C 1 -C 6 ) haloalkyl, (C 1 -C 6 ) haloalkoxy, halogen, —OH, or CN;

each R 22 is independently at each occurrence D, (C 1 -C 6 ) alkyl, (C 1 -C 6 ) alkoxy, (C 1 -C 6 ) haloalkyl, (C 3 -C 8 ) cycloalkyl, (C 6 -C 14 ) aryl, heteroaryl, —O-aryl, —O-heteroaryl, —O-heterocycloalkyl, —O—(C 3 -C 8 )cycloalkyl, —S(O) q (C 1 -C 6 ) alkyl, —C(O)O(C 1 -C 6 ) alkyl, —C(O)NR 23 R 24 , —S(O) q NR 23 R 24 , —NR 23 R 24 , —NR 23 C(O)NR 23 R 24 , —NR 23 C(O)OR 24 , —NR 23 S(O) q R 23 , —NR 23 C(O)R 24 , halogen, —P(O)((C 1 -C 6 )alkyl) 2 , —P(O)(aryl) 2 , —SiMe 3 , —SF 5 or —OH, wherein alkyl, aryl, heteroaryl, heterocycloalkyl, and cycloalkyl are optionally substituted with one or more substituents independently selected from (C 1 -C 6 ) alkyl, (C 1 -C 6 ) haloalkyl, (C 1 -C 6 ) alkoxy, halogen, (C 1 -C 6 ) haloalkoxy, (C 1 -C 6 ) hydroxyalkyl, —OH, CN, —NH 2 , —NH(C 1 -C 4 ) alkyl, —N((C 1 -C 4 ) alkyl) 2 , (C 6 -C 14 ) aryl, heteroaryl, cycloalkyl, or heterocycloalkyl, wherein the aryl, heteroaryl, cycloalkyl, or heterocycloalkyl are optionally substituted one or more substituents independently selected from (C 1 -C 6 ) alkyl, (C 1 -C 6 ) haloalkyl, (C 1 -C 6 ) alkoxy, halogen, (C 1 -C 6 ) haloalkoxy, (C 1 -C 6 ) hydroxyalkyl —OH, CN, —NH 2 , —NH(C 1 -C 4 ) alkyl, or —N((C 1 -C 4 ) alkyl) 2 ;

each R 23 and R 24 is independently at each occurrence H, (C 1 -C 6 ) alkyl, (C 2 -C 6 ) alkenyl, (C 2 -C 6 ) alkynyl, (C 6 -C 14 ) aryl, heteroaryl, (C 5 -C 8 ) cycloalkyl, or heterocycloalkyl;

each m is independently at each occurrence 0, 1, 2, 3, or 4; and

q is independently at each occurrence 0, 1, or 2.

14. The compound of claim 1 , having Formula (Ii)

or a pharmaceutically acceptable salt or tautomer thereof,

wherein:

X 1 is C, S, or S(O);

R 2 is (C 1 -C 8 ) alkyl, (C 6 -C 14 ) aryl, heteroaryl, (C 5 -C 8 ) cycloalkyl, heterocycloalkyl, —NR 25 R 26 , or —OR 25 , wherein the alkyl, aryl, heteroaryl, cycloalkyl, and heterocycloalkyl are optionally substituted with one or more R 8 ;

each R 3 is independently at each occurrence selected from D, (C 1 -C 6 ) alkyl, (C 6 -C 14 ) aryl, heteroaryl, (C 3 -C 8 ) cycloalkyl, or heterocycloalkyl, wherein the alkyl, aryl, heteroaryl, cycloalkyl and heterocycloalkyl are optionally substituted with one or more R 21 ; or

two R 3 together when on adjacent carbons form a (C 3 -C 8 ) cycloalkyl optionally substituted with one or more R 21 ; or two R 3 together form a (C 3 -C 8 ) spirocycloalkyl optionally substituted with one or more R 21 ; or two R 3 together form a spiroheterocycloalkyl optionally substituted with one or more R 21 ; or two R 3 together when on adjacent carbons form an aryl ring optionally substituted with one or more R 21 ; or two R 3 together when on adjacent carbons form an heteroaryl ring optionally substituted with one or more R 21 ;

R 4 is H, (C 1 -C 6 ) alkyl, CD 3 , (C 6 -C 14 ) aryl, heteroaryl, (C 3 -C 8 ) cycloalkyl, or heterocycloalkyl, wherein the alkyl, aryl, heteroaryl, cycloalkyl and heterocycloalkyl are optionally substituted with one or more R 22 ;

R 6 is H, D, or (C 1 -C 6 ) alkyl;

each R 8 is independently D, (C 1 -C 6 ) alkyl, (C 1 -C 6 ) alkoxy, (C 1 -C 6 ) haloalkyl, (C 1 -C 6 ) haloalkoxy, —(C 1 -C 3 )-alkylene-O(C 1 -C 6 ) alkyl, —(C 0 -C 4 )-alkylene-aryl, —(C 0 -C 4 )-alkylene-heteroaryl, (C 3 -C 10 ) cycloalkyl, heterocycloalkyl, —(C 0 -C 4 )-alkylene-O-aryl, —(C 0 -C 4 )-alkylene-O-heteroaryl, —O—(C 3 -C 8 )cycloalkyl, —S-heteroaryl, halogen, —CN, —C(O)R 12 , —CO(O)R 12 , —C(O)NR 12 R 13 , —S(O) q R 12 , —S(O) q NR 12 R 13 , —NR 12 S(O) q R 13 , —(C 0 -C 3 )-alkylene-NR 12 R 13 , —NR 12 C(O)R 13 , —NR 12 C(O)C(O)R 13 , —NR 12 C(O)NR 12 R 13 , —P(O)((C 1 -C 6 )alkyl) 2 , —P(O)(aryl) 2 , —SiMe 3 , —SF 5 , or —OR 12 , wherein alkyl, alkylene, aryl, heteroaryl, cycloalkyl, and heterocycloalkyl are optionally substituted with one or more R 9 ;

each R 9 is independently at each occurrence D, (C 1 -C 6 ) alkyl, (C 1 -C 6 ) alkoxy, (C 3 -C 8 ) cycloalkyl, heterocycloalkyl, (C 6 -C 14 ) aryl, heteroaryl, halogen, —OH, —CN, —C(O)R 14 , —C(O)NR 14 R 15 , —NR 14 C(O)R 15 , —NR 14 R 15 , —S(O) q R 14 , —S(O) q NR 14 R 15 , —NR 14 S(O) q R 15 , oxo, —P(O)((C 1 -C 6 )alkyl) 2 , —P(O)(aryl) 2 , —SiMe 3 , —SF 5 , —O-aryl, CN, or —O-heteroaryl, wherein alkyl, aryl, heteroaryl, cycloalkyl, and heterocycloalkyl are optionally substituted with one or more R 10 ; or

two R 9 together with the atoms to which they are attached form a (C 6 -C 14 ) aryl ring optionally substituted with one or more R 10 ; or two R 9 together with the atoms to which they are attached form a heteroaryl ring optionally substituted with one or more R 10 ; or two R 9 together with the atoms to which they are attached form a (C 5 -C 8 ) cycloalkyl ring optionally substituted with one or more R 10 ; or two R 9 together with the atoms to which they are attached form a heterocycloalkyl ring optionally substituted with one or more R 10 ;

each R 10 is independently at each occurrence (C 1 -C 6 ) alkyl, (C 1 -C 6 ) alkoxy, (C 1 -C 6 ) haloalkyl, (C 1 -C 6 ) haloalkoxy, halogen, —NR 23 C(O)R 24 , —NR 23 S(O) q R 24 , —C(O)R 23 , —C(O)NR 23 R 24 , —NR 23 R 24 , —S(O) q R 23 , —S(O) q NR 23 R 24 , —P(O)((C 1 -C 6 )alkyl) 2 , —P(O)(aryl) 2 , —SiMe 3 , —SF 5 , —OH, or CN; or

two R 10 together with the atoms to which they are attached form a (C 6 -C 14 ) aryl ring optionally substituted with one or more R 11 ; or two R 10 together with the atoms to which they are attached form a heteroaryl ring optionally substituted with one or more R 11 ; or two R 10 together with the atoms to which they are attached form a (C 5 -C 8 ) cycloalkyl ring optionally substituted with one or more R 11 ; or two R 10 together with the atoms to which they are attached form a heterocycloalkyl ring optionally substituted with one or more R 11 ;

each R 11 is independently at each occurrence (C 1 -C 6 ) alkyl, (C 1 -C 6 ) alkoxy, (C 1 -C 6 ) haloalkyl, (C 1 -C 6 ) haloalkoxy, halogen, —OH, —NH 2 , or CN;

each R 12 and R 13 is independently H, (C 1 -C 6 ) alkyl, (C 2 -C 6 ) alkenyl, (C 2 -C 6 ) alkynyl, (C 6 -C 14 ) aryl, heteroaryl, (C 5 -C 8 ) cycloalkyl, or heterocycloalkyl, wherein the alkyl, aryl, heteroaryl, cycloalkyl and heterocycloalkyl are optionally substituted with one or more R 16 ;

each R 14 and R 15 is independently H, (C 1 -C 6 ) alkyl, (C 2 -C 6 ) alkenyl, (C 2 -C 6 ) alkynyl, (C 6 -C 14 ) aryl, heteroaryl, (C 5 -C 8 ) cycloalkyl, or heterocycloalkyl, wherein the alkyl, aryl, heteroaryl, cycloalkyl and heterocycloalkyl are optionally substituted with one or more R 16 ; or

R 14 and R 15 together with the nitrogen to which they are attached form a heterocycloalkyl ring optionally substituted with one or more R 16 , when R 9 is —C(O)NR 14 R 15 ;

each R 16 is independently at each occurrence (C 1 -C 6 ) alkyl, (C 1 -C 6 ) alkoxy, (C 1 -C 6 ) haloalkyl, (C 1 -C 6 ) haloalkoxy, halogen, —OH, or CN;

R 17 is independently H or (C 1 -C 6 ) alkyl;

R 18 is independently (C 1 -C 6 ) alkyl, (C 6 -C 14 ) aryl, heteroaryl, (C 5 -C 8 ) cycloalkyl, or heterocycloalkyl, wherein the alkyl, aryl, heteroaryl, cycloalkyl and heterocycloalkyl are optionally substituted with one or more R 20 ;

R 19 is independently H or (C 1 -C 6 ) alkyl;

each R 20 is independently at each occurrence (C 1 -C 6 ) alkyl, (C 1 -C 6 ) alkoxy, (C 1 -C 6 ) haloalkyl, (C 1 -C 6 ) haloalkoxy, halogen, —OH, CN, (C 6 -C 14 ) aryl, —O(C 6 -C 14 ) aryl, or heteroaryl, wherein the aryl and heteroaryl are optionally substituted with one or more R 21 ; or

two R 20 together with the atoms to which they are attached form a (C 6 -C 14 ) aryl ring optionally substituted with one or more R 21 ; or two R 20 together with the atoms to which they are attached form a heteroaryl ring optionally substituted with one or more R 21 ; or two R 20 together with the atoms to which they are attached form a (C 5 -C 8 ) cycloalkyl ring optionally substituted with one or more R 21 ; or two R 20 together with the atoms to which they are attached form a heterocycloalkyl ring optionally substituted with one or more R 21 ;

each R 21 is independently at each occurrence (C 1 -C 6 ) alkyl, (C 1 -C 6 ) alkoxy, (C 1 -C 6 ) haloalkyl, (C 1 -C 6 ) haloalkoxy, halogen, —OH, or CN;

each R 22 is independently at each occurrence D, (C 1 -C 6 ) alkyl, (C 1 -C 6 ) alkoxy, (C 1 -C 6 ) haloalkyl, (C 3 -C 8 ) cycloalkyl, (C 6 -C 14 ) aryl, heteroaryl, —O-aryl, —O-heteroaryl, —O-heterocycloalkyl, —O—(C 3 -C 8 )cycloalkyl, —S(O) q (C 1 -C 6 ) alkyl, —C(O)O(C 1 -C 6 ) alkyl, —C(O)NR 23 R 24 , —S(O) q NR 23 R 24 , —NR 23 R 24 , —NR 23 C(O)NR 23 R 24 , —NR 23 C(O)OR 24 , —NR 23 S(O) q R 23 , —NR 23 C(O)R 24 , halogen, —P(O)((C 1 -C 6 )alkyl) 2 , —P(O)(aryl) 2 , —SiMe 3 , —SF 5 or —OH, wherein alkyl, aryl, heteroaryl, heterocycloalkyl, and cycloalkyl are optionally substituted with one or more substituents independently selected from (C 1 -C 6 ) alkyl, (C 1 -C 6 ) haloalkyl, (C 1 -C 6 ) alkoxy, halogen, (C 1 -C 6 ) haloalkoxy, (C 1 -C 6 ) hydroxyalkyl, —OH, CN, —NH 2 , —NH(C 1 -C 4 ) alkyl, —N((C 1 -C 4 ) alkyl) 2 , (C 6 -C 14 ) aryl, heteroaryl, cycloalkyl, or heterocycloalkyl, wherein the aryl, heteroaryl, cycloalkyl, or heterocycloalkyl are optionally substituted one or more substituents independently selected from (C 1 -C 6 ) alkyl, (C 1 -C 6 ) haloalkyl, (C 1 -C 6 ) alkoxy, halogen, (C 1 -C 6 ) haloalkoxy, (C 1 -C 6 ) hydroxyalkyl —OH, CN, —NH 2 , —NH(C 1 -C 4 ) alkyl, or —N((C 1 -C 4 ) alkyl) 2 ;

each R 23 and R 24 is independently at each occurrence H, (C 1 -C 6 ) alkyl, (C 2 -C 6 ) alkenyl, (C 2 -C 6 ) alkynyl, (C 6 -C 14 ) aryl, heteroaryl, (C 5 -C 8 ) cycloalkyl, or heterocycloalkyl;

each R 25 and R 26 is independently H, (C 1 -C 6 ) alkyl, (C 2 -C 6 ) alkenyl, (C 2 -C 6 ) alkynyl, (C 6 -C 14 ) aryl, heteroaryl, (C 5 -C 8 ) cycloalkyl, or heterocycloalkyl, wherein the alkyl, alkenyl, alkynyl, aryl, heteroaryl, cycloalkyl, and heterocycloalkyl are optionally substituted with one or more substituents independently selected from (C 1 -C 6 ) alkyl, (C 1 -C 6 ) haloalkyl, (C 1 -C 6 ) alkoxy, halogen, (C 1 -C 6 ) haloalkoxy, (C 1 -C 6 ) hydroxyalkyl, —OH, CN, —NH 2 , —NH(C 1 -C 4 ) alkyl, or —N((C 1 -C 4 ) alkyl) 2 ;

each m is independently at each occurrence 0, 1, 2, 3, or 4; and

q is independently at each occurrence 0, 1, or 2.

15. The compound of claim 1 selected from:

3-((4-hydroxy-1-(3-phenylbutanoyl)piperidin-4-yl)methyl)pyrrolo[2,1-f][1,2,4]triazin-4(3H)-one;

3-((1-([1,1′-biphenyl]-2-carbonyl)-4-hydroxypiperidin-4-yl)methyl)pyrrolo[2,1-f][1,2,4]triazin-4(3H)-one;

3-((4-hydroxy-1-(2-(thiophen-3-yl)benzoyl)piperidin-4-yl)methyl)pyrrolo[2,1-f][1,2,4]triazin-4(3H)-one;

3-((1-(3′-fluoro-[1,1′-biphenyl]-2-carbonyl)-4-hydroxypiperidin-4-yl)methyl)pyrrolo[2,1-f][1,2,4]triazin-4(3H)-one;

3-((1-(3-(benzo[d][1,3]dioxol-5-yl)benzoyl)-4-hydroxypiperidin-4-yl)methyl)pyrrolo[2,1-f][1,2,4]triazin-4(3H)-one;

3-((4-hydroxy-1-(2′-methyl-[1,1′-biphenyl]-3-carbonyl)piperidin-4-yl)methyl)pyrrolo[2,1-f][1,2,4]triazin-4(3H)-one;

3-((4-hydroxy-1-(4′-methyl-[1,1′-biphenyl]-3-carbonyl)piperidin-4-yl)methyl)pyrrolo[2,1-f][1,2,4]triazin-4(3H)-one;

3-((4-hydroxy-1-(4′-methoxy-[1,1′-biphenyl]-3-carbonyl)piperidin-4-yl)methyl)pyrrolo[2,1-f][1,2,4]triazin-4(3H)-one;

3-((1-(4′-fluoro-3′-methyl-[1,1′-biphenyl]-3-carbonyl)-4-hydroxypiperidin-4-yl)methyl)pyrrolo[2,1-f][1,2,4]triazin-4(3H)-one;

3-((4-hydroxy-1-(3′-methoxy-[1,1′-biphenyl]-3-carbonyl)piperidin-4-yl)methyl)pyrrolo[2,1-f][1,2,4]triazin-4(3H)-one;

3-((1-([1,1′-biphenyl]-3-carbonyl)-4-hydroxypiperidin-4-yl)methyl)pyrrolo[2,1-f][1,2,4]triazin-4(3H)-one;

3-((1-(4′-chloro-[1,1′-biphenyl]-3-carbonyl)-4-hydroxypiperidin-4-yl)methyl)pyrrolo[2,1-f][1,2,4]triazin-4(3H)-one;

3-((1-(3′-chloro-[1,1′-biphenyl]-3-carbonyl)-4-hydroxypiperidin-4-yl)methyl)pyrrolo[2,1-f][1,2,4]triazin-4(3H)-one;

3-((4-hydroxy-1-(4′-isopropyl-[1,1′-biphenyl]-3-carbonyl)piperidin-4-yl)methyl)pyrrolo[2,1-f][1,2,4]triazin-4(3H)-one;

3-((4-hydroxy-1-(4′-(trifluoromethyl)-[1,1′-biphenyl]-3-carbonyl)piperidin-4-yl)methyl)pyrrolo[2,1-f][1,2,4]triazin-4(3H)-one;

3′-(4-hydroxy-4-((4-oxopyrrolo[2,1-f][1,2,4]triazin-3 (4H)-yl)methyl)piperidine-1-carbonyl)-[1,1′-biphenyl]-4-carboxamide;

3-((1-(3′,4′-dimethyl-[1,1′-biphenyl]-3-carbonyl)-4-hydroxypiperidin-4-yl)methyl)pyrrolo[2,1-f][1,2,4]triazin-4(3H)-one;

3′-(4-hydroxy-4-((4-oxopyrrolo[2,1-f][1,2,4]triazin-3 (4H)-yl)methyl)piperidine-1-carbonyl)-[1,1′-biphenyl]-2-carbonitrile;

3′-(4-hydroxy-4-((4-oxopyrrolo[2,1-f][1,2,4]triazin-3 (4H)-yl)methyl)piperidine-1-carbonyl)-[1,1′-biphenyl]-4-carbonitrile;

3-((4-hydroxy-1-(3-(5-methylthiophen-2-yl)benzoyl)piperidin-4-yl)methyl)pyrrolo[2,1-f][1,2,4]triazin-4(3H)-one;

3-((4-hydroxy-1-(3-(quinolin-6-yl)benzoyl)piperidin-4-yl)methyl)pyrrolo[2,1-f][1,2,4]triazin-4(3H)-one;

3-((4-hydroxy-1-(3-(imidazo[1,2-a]pyridin-6-yl)benzoyl)piperidin-4-yl)methyl)pyrrolo[2,1-f][1,2,4]triazin-4(3H)-one;

3-((1-(3-(benzo[d]thiazol-5-yl)benzoyl)-4-hydroxypiperidin-4-yl)methyl)pyrrolo[2,1-f][1,2,4]triazin-4(3H)-one;

3-((4-hydroxy-1-(3-(5-methyl-1H-indazol-4-yl)benzoyl)piperidin-4-yl)methyl)pyrrolo[2,1-f][1,2,4]triazin-4(3H)-one;

3-((4-hydroxy-1-(3-(1-methyl-1H-indol-2-yl)benzoyl)piperidin-4-yl)methyl)pyrrolo[2,1-f][1,2,4]triazin-4(3H)-one;

N-cyclopentyl-3′-(4-hydroxy-4-((4-oxopyrrolo[2,1-f][1,2,4]triazin-3 (4H)-yl)methyl)piperidine-1-carbonyl)-[1,1′-biphenyl]-3-carboxamide;

3-((4-hydroxy-1-(3-(thiophen-2-yl)benzoyl)piperidin-4-yl)methyl)pyrrolo[2,1-f][1,2,4]triazin-4(3H)-one;

3-((4-hydroxy-1-(3-(thiophen-3-yl)benzoyl)piperidin-4-yl)methyl)pyrrolo[2,1-f][1,2,4]triazin-4(3H)-one;

3-((1-(2′-fluoro-[1,1′-biphenyl]-3-carbonyl)-4-hydroxypiperidin-4-yl)methyl)pyrrolo[2,1-f][1,2,4]triazin-4(3H)-one;

3-((1-(3′-fluoro-[1,1′-biphenyl]-3-carbonyl)-4-hydroxypiperidin-4-yl)methyl)pyrrolo[2,1-f][1,2,4]triazin-4(3H)-one;

2-(4-(4-hydroxy-4-((4-oxopyrrolo[2,1-f][1,2,4]triazin-3 (4H)-yl)methyl)piperidine-1-carbonyl)phenyl)-2-methylpropanenitrile;

3-((4-hydroxy-1-(2-phenyloxazole-5-carbonyl)piperidin-4-yl)methyl)pyrrolo[2,1-f][1,2,4]triazin-4(3H)-one;

3-((1-(1-(benzo[d]oxazol-2-yl)piperidine-4-carbonyl)-4-hydroxypiperidin-4-yl)methyl)pyrrolo[2,1-f][1,2,4]triazin-4(3H)-one;

3-((1-(3-(1H-pyrazol-1-yl)butanoyl)-4-hydroxypiperidin-4-yl)methyl)pyrrolo[2,1-f][1,2,4]triazin-4(3H)-one;

3-((4-hydroxy-1-(3′-methoxy-[1,1′-biphenyl]-4-carbonyl)piperidin-4-yl)methyl)pyrrolo[2,1-f][1,2,4]triazin-4(3H)-one;

3-((1-([1,1′-biphenyl]-4-carbonyl)-4-hydroxypiperidin-4-yl)methyl)pyrrolo[2,1-f][1,2,4]triazin-4(3H)-one;

3-((1-(3′-ethoxy-[1,1′-biphenyl]-4-carbonyl)-4-hydroxypiperidin-4-yl)methyl)pyrrolo[2,1-f][1,2,4]triazin-4(3H)-one;

4′-(4-hydroxy-4-((4-oxopyrrolo[2,1-f][1,2,4]triazin-3 (4H)-yl)methyl)piperidine-1-carbonyl)-N,N-dimethyl-[1,1′-biphenyl]-4-carboxamide;

3-((4-hydroxy-1-(4′-(pyrrolidine-1-carbonyl)-[1,1′-biphenyl]-4-carbonyl)piperidin-4-yl)methyl)pyrrolo[2,1-f][1,2,4]triazin-4(3H)-one;

3-((1-(2′,5′-dimethoxy-[1,1′-biphenyl]-4-carbonyl)-4-hydroxypiperidin-4-yl)methyl)pyrrolo[2,1-f][1,2,4]triazin-4(3H)-one;

N-ethyl-4′-(4-hydroxy-4-((4-oxopyrrolo[2,1-f][1,2,4]triazin-3 (4H)-yl)methyl)piperidine-1-carbonyl)-[1,1′-biphenyl]-4-carboxamide;

3-((4-hydroxy-1-(4-(quinolin-3-yl)benzoyl)piperidin-4-yl)methyl)pyrrolo[2,1-f][1,2,4]triazin-4(3H)-one;

3-((4-hydroxy-1-(4-(quinolin-6-yl)benzoyl)piperidin-4-yl)methyl)pyrrolo[2,1-f][1,2,4]triazin-4(3H)-one;

3-((1-(3′,5′-dimethoxy-[1,1′-biphenyl]-4-carbonyl)-4-hydroxypiperidin-4-yl)methyl)pyrrolo[2,1-f][1,2,4]triazin-4(3H)-one;

3-((4-hydroxy-1-(4-(2-methylquinolin-6-yl)benzoyl)piperidin-4-yl)methyl)pyrrolo[2,1-f][1,2,4]triazin-4(3H)-one;

3-((4-hydroxy-1-(4-(1-methyl-1H-benzo[d]imidazol-5-yl)benzoyl)piperidin-4-yl)methyl)pyrrolo[2,1-f][1,2,4]triazin-4(3H)-one;

3-((1-(4-(benzo[d]oxazol-5-yl)benzoyl)-4-hydroxypiperidin-4-yl)methyl)pyrrolo[2,1-f][1,2,4]triazin-4(3H)-one;

3-((1-(4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)benzoyl)-4-hydroxypiperidin-4-yl)methyl)pyrrolo[2,1-f][1,2,4]triazin-4(3H)-one;

6-chloro-3-((4-hydroxy-1-(3-phenylbutanoyl)piperidin-4-yl)methyl)pyrrolo[2,1-f][1,2,4]triazin-4(3H)-one;

3-((1-(3-chloro-[1,1′-biphenyl]-4-carbonyl)-4-hydroxypiperidin-4-yl)methyl)pyrrolo[2,1-f][1,2,4]triazin-4(3H)-one;

3-((1-(3-chloro-4′-(pyrrolidine-1-carbonyl)-[1,1′-biphenyl]-4-carbonyl)-4-hydroxypiperidin-4-yl)methyl)pyrrolo[2,1-f][1,2,4]triazin-4(3H)-one;

3-((4-hydroxy-1-(4′-(piperidine-1-carbonyl)-[1,1′-biphenyl]-4-carbonyl)piperidin-4-yl)methyl)pyrrolo[2,1-f][1,2,4]triazin-4(3H)-one;

3-((1-(2-benzyl-3,3-dimethylbutanoyl)-4-hydroxypiperidin-4-yl)methyl)pyrrolo[2,1-f][1,2,4]triazin-4(3H)-one;

2-benzyl-3-(4-hydroxy-4-((4-oxopyrrolo[2,1-f][1,2,4]triazin-3(4H)-yl)methyl)piperidin-1-yl)-3-oxopropanenitrile;

3-((4-hydroxy-1-(4-(2-phenylpropan-2-yl)benzoyl)piperidin-4-yl)methyl)pyrrolo[2,1-f][1,2,4]triazin-4(3H)-one;

(R)-3-((4-hydroxy-1-(3-phenylbutanoyl)piperidin-4-yl)methyl)pyrrolo[2, 1-f][1,2,4]triazin-4(3H)-one;

3-((1-(3-(1H-pyrrol-1-yl)butanoyl)-4-hydroxypiperidin-4-yl)methyl)pyrrolo[2,1-f][1,2,4]triazin-4(3H)-one;

3-((4-hydroxy-1-(2-(1,2,3,4-tetrahydronaphthalen-2-yl)acetyl)piperidin-4-yl)methyl)pyrrolo[2,1-f][1,2,4]triazin-4(3H)-one;

3-((4-hydroxy-1-(4-(thiazol-4-yl)benzoyl)piperidin-4-yl)methyl)pyrrolo[2,1-f][1,2,4]triazin-4(3H)-one;

3-((1-(2-benzylbutanoyl)-4-hydroxypiperidin-4-yl)methyl)pyrrolo[2,1-f][1,2,4]triazin-4(3H)-one;

3-((4-hydroxy-1-(4-(phenylsulfonyl)benzoyl)piperidin-4-yl)methyl)pyrrolo[2, 1-f][1,2,4]triazin-4(3H)-one;

3-((4-hydroxy-1-(4-(phenylthio)benzoyl)piperidin-4-yl)methyl)pyrrolo[2,1-f][1,2,4]triazin-4(3H)-one;

3-((4-hydroxy-1-(2-methyl-3-phenylpropanoyl)piperidin-4-yl)methyl)pyrrolo[2,1-f][1,2,4]triazin-4(3H)-one;

3-((1-(4-((1H-benzo[d]imidazol-1-yl)methyl)benzoyl)-4-hydroxypiperidin-4-yl)methyl)pyrrolo[2,1-f][1,2,4]triazin-4(3H)-one;

3-((1-(4-((1H-pyrazol-1-yl)methyl)benzoyl)-4-hydroxypiperidin-4-yl)methyl)pyrrolo[2,1-f][1,2,4]triazin-4(3H)-one;

3-((4-hydroxy-1-(4-((5-methyl-1H-tetrazol-1-yl)methyl)benzoyl)piperidin-4-yl)methyl)pyrrolo[2,1-f][1,2,4]triazin-4(3H)-one;

3-((4-hydroxy-1-(4-((5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl)methyl)benzoyl)piperidin-4-yl)methyl)pyrrolo[2,1-f][1,2,4]triazin-4(3H)-one;

3-((1-(4-((1H-benzo[d][1,2,3]triazol-1-yl)methyl)benzoyl)-4-hydroxypiperidin-4-yl)methyl)pyrrolo[2,1-f][1,2,4]triazin-4(3H)-one;

3-((1-(4-((3,5-dimethyl-1H-pyrazol-1-yl)methyl)benzoyl)-4-hydroxypiperidin-4-yl)methyl)pyrrolo[2,1-f][1,2,4]triazin-4(3H)-one;

3-((4-hydroxy-1-(4-(thiophen-2-ylmethyl)benzoyl)piperidin-4-yl)methyl)pyrrolo[2,1-f][1,2,4]triazin-4(3H)-one;

3-((1-(4-benzoylbenzoyl)-4-hydroxypiperidin-4-yl)methyl)pyrrolo[2,1-f][1,2,4]triazin-4(3H)-one;

3-((1-(4-(ethyl(phenyl)amino)benzoyl)-4-hydroxypiperidin-4-yl)methyl)pyrrolo[2,1-f][1,2,4]triazin-4(3H)-one;

4-(4-(4-hydroxy-4-((4-oxopyrrolo[2,1-f][1,2,4]triazin-3 (4H)-yl)methyl)piperidine-1-carbonyl)piperazin-1-yl)benzonitrile;

3-((4-hydroxy-1-(4-(4-(methyl sulfonyl)phenyl)piperazine-1-carbonyl)piperidin-4-yl)methyl)pyrrolo[2,1-f][1,2,4]triazin-4(3H)-one;

3-((1-(2-chloro-4-(piperidin-1-ylmethyl)benzoyl)-4-hydroxypiperidin-4-yl)methyl)pyrrolo[2,1-f][1,2,4]triazin-4(3H)-one;

3-((4-hydroxy-1-(3-phenylbutanoyl)piperidin-4-yl)methyl)-7-methylpyrrolo[2,1-f][1,2,4]triazin-4(3H)-one;

3-((4-hydroxy-1-(2-methyl-3-phenylpropanoyl)piperidin-4-yl)methyl)-7-methylpyrrolo[2,1-f][1,2,4]triazin-4(3H)-one;

3′-chloro-4′-(4-hydroxy-4-((4-oxopyrrolo[2,1-f][1,2,4]triazin-3 (4H)-yl)methyl)piperidine-1-carbonyl)-N,N-dimethyl-[1,1′-biphenyl]-4-carboxamide;

3-((1-(3-chloro-4′-(piperidine-1-carbonyl)-[1,1′-biphenyl]-4-carbonyl)-4-hydroxypiperidin-4-yl)methyl)pyrrolo[2,1-f][1,2,4]triazin-4(3H)-one;

3-((4-hydroxy-1-(4-phenoxybenzoyl)piperidin-4-yl)methyl)pyrrolo[2,1-f][1,2,4]triazin-4(3H)-one;

(R)—N-(3-((4-hydroxy-1-(3-phenylbutanoyl)piperidin-4-yl)methyl)-4-oxo-3,4-dihydropyrrolo[2,1-f][1,2,4]triazin-6-yl)acetamide;

(R)-1-(3-((4-hydroxy-1-(3-phenylbutanoyl)piperidin-4-yl)methyl)-4-oxo-3,4-dihydropyrrolo[2,1-f][1,2,4]triazin-6-yl)-3-methylurea;

3-((4-hydroxy-1-(3-phenylbutanoyl)piperidin-4-yl)methyl)-6-methylpyrrolo[2,1-f][1,2,4]triazin-4(3H)-one;

3-((4-hydroxy-1-(2-methyl-3-phenylpropanoyl)piperidin-4-yl)methyl)-6-methylpyrrolo[2,1-f][1,2,4]triazin-4(3H)-one;

1-(3-chlorophenyl)-3-(3-((1-(cyclopropanecarbonyl)-4-hydroxypiperidin-4-yl)methyl)-4-oxo-3,4-dihydropyrrolo[2,1-f][1,2,4]triazin-6-yl)urea;

1-(3-((1-(cyclopropanecarbonyl)-4-hydroxypiperidin-4-yl)methyl)-4-oxo-3,4-dihydropyrrolo[2,1-f][1,2,4]triazin-6-yl)-3-(m-tolyl)urea;

1-(3-((1-(cyclopropanecarbonyl)-4-hydroxypiperidin-4-yl)methyl)-4-oxo-3,4-dihydropyrrolo[2,1-f][1,2,4]triazin-6-yl)-3-(4-fluorobenzyl)urea;

1-(3-((1-(cyclopropanecarbonyl)-4-hydroxypiperidin-4-yl)methyl)-4-oxo-3,4-dihydropyrrolo[2,1-f][1,2,4]triazin-6-yl)-3-(4-fluorophenyl)urea;

1-(3-((1-(cyclopropanecarbonyl)-4-hydroxypiperidin-4-yl)methyl)-4-oxo-3,4-dihydropyrrolo[2,1-f][1,2,4]triazin-6-yl)-3-(p-tolyl)urea;

1-(3-((1-(cyclopropanecarbonyl)-4-hydroxypiperidin-4-yl)methyl)-4-oxo-3,4-dihydropyrrolo[2,1-f][1,2,4]triazin-6-yl)-3-(2,3-dihydro-1H-inden-5-yl)urea;

1-(4-chlorobenzyl)-3-(3-((1-(cyclopropanecarbonyl)-4-hydroxypiperidin-4-yl)methyl)-4-oxo-3,4-dihydropyrrolo[2,1-f][1,2,4]triazin-6-yl)urea;

1-(3-((1-(cyclopropanecarbonyl)-4-hydroxypiperidin-4-yl)methyl)-4-oxo-3,4-dihydropyrrolo[2,1-f][1,2,4]triazin-6-yl)-3-(4-methylbenzyl)urea;

1-(3-((1-(cyclopropanecarbonyl)-4-hydroxypiperidin-4-yl)methyl)-4-oxo-3,4-dihydropyrrolo[2,1-f][1,2,4]triazin-6-yl)-3-(3,5-difluorophenyl)urea;

1-(3-((1-(cyclopropanecarbonyl)-4-hydroxypiperidin-4-yl)methyl)-4-oxo-3,4-dihydropyrrolo[2,1-f][1,2,4]triazin-6-yl)-3-(2-fluorobenzyl)urea;

(R)-1-(3-((1-(cyclopropanecarbonyl)-4-hydroxypiperidin-4-yl)methyl)-4-oxo-3,4-dihydropyrrolo [2,1-f][1,2,4]triazin-6-yl)-3-(1-phenylethyl)urea;

1-(3-((1-(cyclopropanecarbonyl)-4-hydroxypiperidin-4-yl)methyl)-4-oxo-3,4-dihydropyrrolo[2,1-f][1,2,4]triazin-6-yl)-3-(3-fluorophenyl)urea;

1-(3-((1-(cyclopropanecarbonyl)-4-hydroxypiperidin-4-yl)methyl)-4-oxo-3,4-dihydropyrrolo[2,1-f][1,2,4]triazin-6-yl)-3-(3-fluoro-2-methylphenyl)urea;

1-(3-((1-(cyclopropanecarbonyl)-4-hydroxypiperidin-4-yl)methyl)-4-oxo-3,4-dihydropyrrolo[2,1-f][1,2,4]triazin-6-yl)-3-(2,3-dimethylphenyl)urea;

1-(3-((1-(cyclopropanecarbonyl)-4-hydroxypiperidin-4-yl)methyl)-4-oxo-3,4-dihydropyrrolo[2,1-f][1,2,4]triazin-6-yl)-3-(2,4-dimethylphenyl)urea;

1-(4-cyanophenyl)-3-(3-((1-(cyclopropanecarbonyl)-4-hydroxypiperidin-4-yl)methyl)-4-oxo-3,4-dihydropyrrolo[2,1-f][1,2,4]triazin-6-yl)urea;

1-(3-((1-(cyclopropanecarbonyl)-4-hydroxypiperidin-4-yl)methyl)-4-oxo-3,4-dihydropyrrolo[2,1-f][1,2,4]triazin-6-yl)-3-(3-methoxyphenyl)urea;

N-(3-((1-(cyclopropanecarbonyl)-4-hydroxypiperidin-4-yl)methyl)-4-oxo-3,4-dihydropyrrolo[2,1-f][1,2,4]triazin-6-yl)-4-(trifluoromethyl)benzamide;

N-(3-((1-(cyclopropanecarbonyl)-4-hydroxypiperidin-4-yl)methyl)-4-oxo-3,4-dihydropyrrolo[2,1-f][1,2,4]triazin-6-yl)-2-(2, 6-dichlorophenyl)acetamide;

N-(3-((1-(cyclopropanecarbonyl)-4-hydroxypiperidin-4-yl)methyl)-4-oxo-3,4-dihydropyrrolo[2,1-f][1,2,4]triazin-6-yl)-2-(4-(trifluoromethoxy)phenoxy)acetamide;

N-(3-((1-(cyclopropanecarbonyl)-4-hydroxypiperidin-4-yl)methyl)-4-oxo-3,4-dihydropyrrolo[2,1-f][1,2,4]triazin-6-yl)-2-(3,4-dichlorophenoxy)acetamide;

N-(3-((1-(cyclopropanecarbonyl)-4-hydroxypiperidin-4-yl)methyl)-4-oxo-3,4-dihydropyrrolo[2,1-f][1,2,4]triazin-6-yl)-2-(2,3-dichlorophenoxy)acetamide;

N-(3-((1-(cyclopropanecarbonyl)-4-hydroxypiperidin-4-yl)methyl)-4-oxo-3,4-dihydropyrrolo[2,1-f][1,2,4]triazin-6-yl)-3,4-dimethylbenzamide;

3-chloro-N-(3-((1-(cyclopropanecarbonyl)-4-hydroxypiperidin-4-yl)methyl)-4-oxo-3,4-dihydropyrrolo[2,1-f][1,2,4]triazin-6-yl)-4-methylbenzamide;

N-(3-((1-(cyclopropanecarbonyl)-4-hydroxypiperidin-4-yl)methyl)-4-oxo-3,4-dihydropyrrolo[2,1-f][1,2,4]triazin-6-yl)-2, 5-dimethylbenzamide;

N-(3-((1-(cyclopropanecarbonyl)-4-hydroxypiperidin-4-yl)methyl)-4-oxo-3,4-dihydropyrrolo[2,1-f][1,2,4]triazin-6-yl)-2-(trifluoromethoxy)benzamide;

2,4-dichloro-N-(3-((1-(cyclopropanecarbonyl)-4-hydroxypiperidin-4-yl)methyl)-4-oxo-3,4-dihydropyrrolo[2,1-f][1,2,4]triazin-6-yl)benzamide;

N-(3-((1-(cyclopropanecarbonyl)-4-hydroxypiperidin-4-yl)methyl)-4-oxo-3,4-dihydropyrrolo[2,1-f][1,2,4]triazin-6-yl)-2-phenylthiazole-4-carboxamide;

3-(4-chlorophenyl)-N-(3-((1-(cyclopropanecarbonyl)-4-hydroxypiperidin-4-yl)methyl)-4-oxo-3,4-dihydropyrrolo[2,1-f][1,2,4]triazin-6-yl)butanamide;

N-(4′-(4-hydroxy-4-((4-oxopyrrolo[2,1-f][1,2,4]triazin-3 (4H)-yl)methyl)piperidine-1-carbonyl)-[1,1′-biphenyl]-2-yl)methacrylamide;

3-((1-benzoyl-4-hydroxypiperidin-4-yl)methyl)-7-phenylimidazo[5,1-f][1,2,4]triazin-4(3H)-one;

3-((1-(4-fluorobenzoyl)-4-hydroxypiperidin-4-yl)methyl)-7-(4-fluorophenyl)imidazo[5, 1-J][1,2,4]triazin-4(3H)-one;

3-((1-(4-fluorobenzoyl)-4-hydroxypiperidin-4-yl)methyl)-7-p-tolylimidazo [1,5-f][1,2,4]triazin-4 (3H)-one;

3-([4-Hydroxy-1-[3-(1H-pyrazol-1-yl)butanoyl]piperidin-4-yl]methyl)-7-(4-methylphenyl)-3H,4H-imidazo[4,3-f][1,2,4]triazin-4-one;

(S)-3-((1-(3-(1H-pyrazol-1-yl)butanoyl)-4-hydroxypiperidin-4-yl)methyl)-7-(p-tolyl) imidazo[5,1-f][1,2,4]triazin-4(3H)-one;

(R)-3-((1-(3-(1H-pyrazol-1-yl)butanoyl)-4-hydroxypiperidin-4-yl)methyl)-7-(p-tolyl) imidazo[5,1-f][1,2,4]triazin-4(3H)-one;

3-((1-(2-cyclopropyloxazole-5-carbonyl)-4-hydroxypiperidin-4-yl)methyl)-7-(4-fluorophenyl) imidazo[5,1-f][1,2,4]triazin-4(3H)-one;

3-((1-(4-(1H-pyrazol-1-yl)benzoyl)-4-hydroxypiperidin-4-yl)methyl)-7-(4-fluorophenyl) imidazo[5,1-f][1,2,4]triazin-4(3H)-one;

7-(4-fluorophenyl)-3-((4-hydroxy-1-(4-methylbenzoyl)piperidin-4-yl)methyl)imidazo[5, 1-f][1,2,4]triazin-4(3H)-one; or

3-((1-(3-fluoro-4-methylbenzoyl)-4-hydroxypiperidin-4-yl)methyl)-7-(4-fluorophenyl) imidazo[5,1-f][1,2,4]triazin-4(3H)-one,

or a pharmaceutically acceptable salt thereof.

16. A pharmaceutical composition comprising, a compound of claim 1 and a pharmaceutically acceptable carrier.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Oct 17, 2023
From: FIRST-CITIZENS BANK & TRUST COMPANY, AS AGENT
To: VALO HEALTH, INC.; VALO HEALTH, LLC
Reel/Frame 065255/0660 →
SECURITY INTEREST Recorded Jul 6, 2023
From: VALO HEALTH, LLC; VALO HEALTH, INC.
To: FIRST-CITIZENS BANK & TRUST COMPANY, AS AGENT
Reel/Frame 064207/0957 →
MERGER Recorded Sep 8, 2021
From: VALO EARLY DISCOVERY, INC.
To: VALO HEALTH, INC.
Reel/Frame 057438/0025 →
CHANGE OF NAME Recorded Sep 16, 2020
From: INTEGRAL EARLY DISCOVERY, INC.
To: VALO EARLY DISCOVERY, INC.
Reel/Frame 053787/0138 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 5, 2020
From: FORMA THERAPEUTICS, INC.
To: INTEGRAL EARLY DISCOVERY, INC.
Reel/Frame 053402/0298 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 19, 2016
From: IOANNIDIS, STEPHANOS; TALBOT, ADAM CHARLES; FOLLOWS, BRUCE; BUCKMELTER, ALEXANDRE JOSEPH; WANG, MINGHUA; CAMPBELL, ANN-MARIE
To: FORMA THERAPEUTICS, INC.
Reel/Frame 037523/0395 →
Continuity (2)
Provisional Application 62098145 · Dec 30, 2014
Related Publication 20160185786A1 · Jun 30, 2016